Skip to main content
Top
Published in: Nutrition Journal 1/2008

Open Access 01-12-2008 | Research

Evaluation of metabolic syndrome in adults of Talca city, Chile

Authors: Veronica Mujica, Elba Leiva, Gloria Icaza, Nora Diaz, Miguel Arredondo, Rodrigo Moore-Carrasco, Roxana Orrego, Marcela Vásquez, Ivan Palomo

Published in: Nutrition Journal | Issue 1/2008

Login to get access

Abstract

Objective-

Insulin resistance (IR) is an important risk factor for type 2 Diabetes Mellitus (DM2) and cardiovascular disease (CVD). Metabolic Syndrome (MS) is a clustering of metabolic alterations associated to IR; however, there is no international consensus for defining its diagnosis. Our objective was to evaluate the prevalence and characteristics of MS identified by the ATP III and IDF criteria in adults from Talca city.

Research and methods-

We studied 1007 individuals, aged 18–74, and residents from Talca. MS subjects were defined according to ATP III (three altered factors) and IDF criteria (patients with waist circumference >80/90 cm (W/M) and two others altered factors).

Results-

The prevalence of metabolic syndrome according to the IDF and ATP III criteria was 36.4% and 29.5%, respectively after adjustment for age and sex. The agreement for both criteria was 89%. The prevalence in men was higher than in women for both MS definitions, although not significant. MS probability increased with age, and the highest risk was in the 57–68 age group (ATP-MS) and 53–72 age group (IDF-MS). Hypertension, high triglycerides and abdominal obesity are the most frequent alterations in MS.

Conclusion-

MS prevalence in adults was higher when diagnosed with IDF than with ATP criterion; in both, age is directly related with the MS presence. The MS subjects showed higher levels of blood pressure, waist circumference and plasma triglycerides. Considering our results, it is worrisome that one third of our population has a high risk of developing DM2 and CVD in the future.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-Defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III Participants Age 50 Years and Older. Diabetes. 2003, 52: 1210-14. 10.2337/diabetes.52.5.1210.PubMedCrossRef Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-Defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III Participants Age 50 Years and Older. Diabetes. 2003, 52: 1210-14. 10.2337/diabetes.52.5.1210.PubMedCrossRef
2.
go back to reference Reaven GM: Insulin resistance, cardiovascular disease and the metabolic syndrome: how well do the emperor's clothes fit?. Diabetes Care. 2004, 27: 1011-1012. 10.2337/diacare.27.4.1011.PubMedCrossRef Reaven GM: Insulin resistance, cardiovascular disease and the metabolic syndrome: how well do the emperor's clothes fit?. Diabetes Care. 2004, 27: 1011-1012. 10.2337/diacare.27.4.1011.PubMedCrossRef
3.
go back to reference Abdul-Ghani MA, Tripathy D, De Fronzo RA: Contributions of Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose. Diabetes Care. 2006, 29: 1130-1139. 10.2337/dc05-2179.PubMedCrossRef Abdul-Ghani MA, Tripathy D, De Fronzo RA: Contributions of Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose. Diabetes Care. 2006, 29: 1130-1139. 10.2337/dc05-2179.PubMedCrossRef
4.
go back to reference Hollenbeck C, Reaven GM: Variations in insulin stimulated glucose uptake in healthy individuals with glucose intolerance. J Clin Endocrinol Metab. 1987, 64: 1169-73.PubMedCrossRef Hollenbeck C, Reaven GM: Variations in insulin stimulated glucose uptake in healthy individuals with glucose intolerance. J Clin Endocrinol Metab. 1987, 64: 1169-73.PubMedCrossRef
5.
go back to reference Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome. Diabetes Care. 2001, 24: 683-89. 10.2337/diacare.24.4.683.PubMedCrossRef Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome. Diabetes Care. 2001, 24: 683-89. 10.2337/diacare.24.4.683.PubMedCrossRef
6.
go back to reference Lorenzo C, Williams K, Hunt KJ, Haffner SM: Metabolic Syndrome and Its Impact on Cardiovascular Disease Incident, the San Antonio Heart Study. Diabetes Care. 2006, 29: 625-630. 10.2337/diacare.29.03.06.dc05-1755.PubMedCrossRef Lorenzo C, Williams K, Hunt KJ, Haffner SM: Metabolic Syndrome and Its Impact on Cardiovascular Disease Incident, the San Antonio Heart Study. Diabetes Care. 2006, 29: 625-630. 10.2337/diacare.29.03.06.dc05-1755.PubMedCrossRef
7.
go back to reference Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M: Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population: The Bruneck Study. Diabetes Care. 2007, 30: 318-324. 10.2337/dc06-0919.PubMedCrossRef Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M: Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General Population: The Bruneck Study. Diabetes Care. 2007, 30: 318-324. 10.2337/dc06-0919.PubMedCrossRef
8.
go back to reference Hanley AJ, Williams K, Stern MP, Haffner SM: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care. 2002, 25: 1177-1184. 10.2337/diacare.25.7.1177.PubMedCrossRef Hanley AJ, Williams K, Stern MP, Haffner SM: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care. 2002, 25: 1177-1184. 10.2337/diacare.25.7.1177.PubMedCrossRef
9.
go back to reference Mathews DR, Hosker JP, Rudensky AS, Taylor BA, Treacher DF: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985, 28 (7): 412-419. 10.1007/BF00280883.CrossRef Mathews DR, Hosker JP, Rudensky AS, Taylor BA, Treacher DF: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985, 28 (7): 412-419. 10.1007/BF00280883.CrossRef
10.
go back to reference Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.PubMedCrossRef Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.PubMedCrossRef
11.
go back to reference Reaven G: Rol of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607. 10.2337/diabetes.37.12.1595.PubMedCrossRef Reaven G: Rol of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607. 10.2337/diabetes.37.12.1595.PubMedCrossRef
12.
go back to reference Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins A, Klein R, Garvey WT: Critical evaluation of the Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004, 27: 978-983. 10.2337/diacare.27.4.978.PubMedCrossRef Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins A, Klein R, Garvey WT: Critical evaluation of the Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004, 27: 978-983. 10.2337/diacare.27.4.978.PubMedCrossRef
13.
go back to reference WHO consultation: Definition, diagnosis and classification of diabetes mellitus and its complication. WHO/NCD/99.2. 31-33. WHO consultation: Definition, diagnosis and classification of diabetes mellitus and its complication. WHO/NCD/99.2. 31-33.
14.
go back to reference Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and treatment of High Cholesterol. JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and treatment of High Cholesterol. JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
15.
go back to reference Deurenberg P, Yap M, van Staveren WA: Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998, 22: 1164-1171. 10.1038/sj/ijo/0800741.PubMedCrossRef Deurenberg P, Yap M, van Staveren WA: Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998, 22: 1164-1171. 10.1038/sj/ijo/0800741.PubMedCrossRef
16.
go back to reference Palaniappan LP, Carnethon MR, Fortmann SP: Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. Diabetes Care. 2002, 25: 1351-1357. 10.2337/diacare.25.8.1351.PubMedCrossRef Palaniappan LP, Carnethon MR, Fortmann SP: Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. Diabetes Care. 2002, 25: 1351-1357. 10.2337/diacare.25.8.1351.PubMedCrossRef
17.
go back to reference Liu J, Hanley AJ, Young TK, Harris SB, Zinman B: Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes (Lond). 2006, 30: 669-676. 10.1038/sj.ijo.0803179.CrossRef Liu J, Hanley AJ, Young TK, Harris SB, Zinman B: Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes (Lond). 2006, 30: 669-676. 10.1038/sj.ijo.0803179.CrossRef
18.
go back to reference Rush E, Plank L, Chandu V, Laulu M, Simmons D, Swinburn B, Yajnik C: Body size, body composition, and fat distribution: a comparison of young New Zealand men of European, Pacific Island, and Asian Indian ethnicities. N Z Med J. 2004, 117: U1203-PubMed Rush E, Plank L, Chandu V, Laulu M, Simmons D, Swinburn B, Yajnik C: Body size, body composition, and fat distribution: a comparison of young New Zealand men of European, Pacific Island, and Asian Indian ethnicities. N Z Med J. 2004, 117: U1203-PubMed
19.
go back to reference Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444: 881-887. 10.1038/nature05488.PubMedCrossRef Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444: 881-887. 10.1038/nature05488.PubMedCrossRef
20.
go back to reference Examination Committee of Criteria for "Obesity Disease" in Japan, the Japan Society for the Study of Obesity: New criteria for "obesity disease" in Japan. Circ J. 2002, 66: 987-992. 10.1253/circj.66.987.CrossRef Examination Committee of Criteria for "Obesity Disease" in Japan, the Japan Society for the Study of Obesity: New criteria for "obesity disease" in Japan. Circ J. 2002, 66: 987-992. 10.1253/circj.66.987.CrossRef
21.
go back to reference Alberti KG, Zimmet P, Shaw J: IDF Epidemiology Task Force Consensus Group: The metabolic syndrome -a worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed Alberti KG, Zimmet P, Shaw J: IDF Epidemiology Task Force Consensus Group: The metabolic syndrome -a worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
22.
go back to reference Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN: The Importance of Waist Circumference in the Definition of Metabolic Syndrome: Prospective analyses of mortality in men. Diabetes Care. 2006, 29 (2): 404-409. 10.2337/diacare.29.02.06.dc05-1636.PubMedCrossRef Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN: The Importance of Waist Circumference in the Definition of Metabolic Syndrome: Prospective analyses of mortality in men. Diabetes Care. 2006, 29 (2): 404-409. 10.2337/diacare.29.02.06.dc05-1636.PubMedCrossRef
23.
go back to reference Shaw JE, Zimmet PZ, Alberti KG: Point: Impaired Fasting Glucose: The Case for the New American Diabetes Association Criterion. Diabetes Care. 2006, 29 (5): 1170-1172. 10.2337/dc06-0013.PubMedCrossRef Shaw JE, Zimmet PZ, Alberti KG: Point: Impaired Fasting Glucose: The Case for the New American Diabetes Association Criterion. Diabetes Care. 2006, 29 (5): 1170-1172. 10.2337/dc06-0013.PubMedCrossRef
24.
go back to reference Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: The American Heart Association, National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2005, 112: e285-90. 10.1161/CIRCULATIONAHA.105.169405. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: The American Heart Association, National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2005, 112: e285-90. 10.1161/CIRCULATIONAHA.105.169405.
25.
go back to reference Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005, 54: 3252-3257. 10.2337/diabetes.54.11.3252.PubMedCrossRef Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005, 54: 3252-3257. 10.2337/diabetes.54.11.3252.PubMedCrossRef
26.
go back to reference Grima A, León M, Ordoñez B: El síndrome metabólico como factor de riesgo cardiovascular. Rev Esp Cardiol Supl. 2005, 5: 16D-20D. 10.1157/13083444.CrossRef Grima A, León M, Ordoñez B: El síndrome metabólico como factor de riesgo cardiovascular. Rev Esp Cardiol Supl. 2005, 5: 16D-20D. 10.1157/13083444.CrossRef
27.
go back to reference Sierra-Johnson J, Johnson BD, Allison TG, Bailey KR, Schwartz GL, Turner ST: Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin. Diabetes Care. 2006, 29: 668-672. 10.2337/diacare.29.03.06.dc05-0970.PubMedCrossRef Sierra-Johnson J, Johnson BD, Allison TG, Bailey KR, Schwartz GL, Turner ST: Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin. Diabetes Care. 2006, 29: 668-672. 10.2337/diacare.29.03.06.dc05-0970.PubMedCrossRef
28.
go back to reference Ministerio de Salud de Chile: Encuesta Nacional de Salud 2003. 2003, Departamento de Salud Pública de la Pontificia Universidad Católica de Chile: Informe Técnico Ministerio de Salud de Chile: Encuesta Nacional de Salud 2003. 2003, Departamento de Salud Pública de la Pontificia Universidad Católica de Chile: Informe Técnico
29.
go back to reference Palomo I, Icaza G, Mujica V, Leiva E, Vásquez M, Alarcón M: Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile 2005. Rev Med Chile. 2007, 135: 904-912.PubMedCrossRef Palomo I, Icaza G, Mujica V, Leiva E, Vásquez M, Alarcón M: Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile 2005. Rev Med Chile. 2007, 135: 904-912.PubMedCrossRef
30.
go back to reference Kish L: Muestreo de encuesta. 1972, México: Trillas Kish L: Muestreo de encuesta. 1972, México: Trillas
31.
go back to reference Pfeiffer R, Castle P: With or without a gold standard. Epidemiology. 2005, 16 (5): 595-95. 10.1097/01.ede.0000173328.31497.ec.PubMedCrossRef Pfeiffer R, Castle P: With or without a gold standard. Epidemiology. 2005, 16 (5): 595-95. 10.1097/01.ede.0000173328.31497.ec.PubMedCrossRef
32.
go back to reference Hastie T, Tibshirani R: Generalized additive models for medical research. Statistical Methods in Medical Research. 1995, 4: 187-196. 10.1177/096228029500400302.PubMedCrossRef Hastie T, Tibshirani R: Generalized additive models for medical research. Statistical Methods in Medical Research. 1995, 4: 187-196. 10.1177/096228029500400302.PubMedCrossRef
33.
go back to reference Park HS, Lee SY, Kim SM, Han JH, Kim DJ: Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. Diabetes Care. 2006, 29: 933-934. 10.2337/diacare.29.04.06.dc06-0069.PubMedCrossRef Park HS, Lee SY, Kim SM, Han JH, Kim DJ: Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. Diabetes Care. 2006, 29: 933-934. 10.2337/diacare.29.04.06.dc06-0069.PubMedCrossRef
34.
go back to reference Boehm BO, Claudi-Boehm S, Yildirim S: Prevalence of the Metabolic Syndrome in Southwest Germany. Scand J Clin Lab Invest Suppl. 2005, 240: 122-128. 10.1080/00365510500236309.PubMedCrossRef Boehm BO, Claudi-Boehm S, Yildirim S: Prevalence of the Metabolic Syndrome in Southwest Germany. Scand J Clin Lab Invest Suppl. 2005, 240: 122-128. 10.1080/00365510500236309.PubMedCrossRef
35.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the Metabolic Syndrome Among US Adults Findings From the Third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.PubMedCrossRef Ford ES, Giles WH, Dietz WH: Prevalence of the Metabolic Syndrome Among US Adults Findings From the Third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.PubMedCrossRef
36.
go back to reference Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD: Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Asia Pac J Clin Nutr. 2003, 12 (3): 271-6.PubMed Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD: Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Asia Pac J Clin Nutr. 2003, 12 (3): 271-6.PubMed
37.
go back to reference Cordero A, Alegría E, Leon M: Prevalencia de Síndrome Metabólico. Rev Esp Cardiol. 2006, 5: 11-15. 10.1157/13083443.CrossRef Cordero A, Alegría E, Leon M: Prevalencia de Síndrome Metabólico. Rev Esp Cardiol. 2006, 5: 11-15. 10.1157/13083443.CrossRef
38.
go back to reference Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2003, 61: 29-37. 10.1016/S0168-8227(03)00066-4.PubMedCrossRef Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2003, 61: 29-37. 10.1016/S0168-8227(03)00066-4.PubMedCrossRef
39.
go back to reference Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V: Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP criteria. Diabetes Res Clin Pract. 2003, 60: 199-204. 10.1016/S0168-8227(03)00060-3.PubMedCrossRef Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V: Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP criteria. Diabetes Res Clin Pract. 2003, 60: 199-204. 10.1016/S0168-8227(03)00060-3.PubMedCrossRef
40.
go back to reference Gustiene O, Slapikas R, Klumbiene J, Sakalauskiene G, Kubilius R, Bagdzeviciûte S, Zaliûnas R: The prevalence of Metabolic Syndrome in middle-aged in Kaunas population. Medicine Kaunas. 2005, 41 (10): 867-76. Gustiene O, Slapikas R, Klumbiene J, Sakalauskiene G, Kubilius R, Bagdzeviciûte S, Zaliûnas R: The prevalence of Metabolic Syndrome in middle-aged in Kaunas population. Medicine Kaunas. 2005, 41 (10): 867-76.
41.
go back to reference Bustos P, Da Silva A, Amigo H, Bettiol H, Barbieri M: Metabolic syndrome in young adults from two socioeconomic Latin American settings. Nutr Metab Cardiovasc Dis. 2007, 17: 581-9. 10.1016/j.numecd.2006.06.001.PubMedCrossRef Bustos P, Da Silva A, Amigo H, Bettiol H, Barbieri M: Metabolic syndrome in young adults from two socioeconomic Latin American settings. Nutr Metab Cardiovasc Dis. 2007, 17: 581-9. 10.1016/j.numecd.2006.06.001.PubMedCrossRef
42.
go back to reference Miccoli R, Bianchi C, Odoguardi L, Penno G, Caricato F: Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis. 2005, 15 (4): 250-4. 10.1016/j.numecd.2004.09.002.PubMedCrossRef Miccoli R, Bianchi C, Odoguardi L, Penno G, Caricato F: Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis. 2005, 15 (4): 250-4. 10.1016/j.numecd.2004.09.002.PubMedCrossRef
43.
go back to reference De Simone G, Devereux RB, Chinali M: Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population with High Prevalence of Obesity and Diabetes. Diabetes Care. 2007, 30 (7): 1851-56. 10.2337/dc06-2152.PubMedCrossRef De Simone G, Devereux RB, Chinali M: Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population with High Prevalence of Obesity and Diabetes. Diabetes Care. 2007, 30 (7): 1851-56. 10.2337/dc06-2152.PubMedCrossRef
Metadata
Title
Evaluation of metabolic syndrome in adults of Talca city, Chile
Authors
Veronica Mujica
Elba Leiva
Gloria Icaza
Nora Diaz
Miguel Arredondo
Rodrigo Moore-Carrasco
Roxana Orrego
Marcela Vásquez
Ivan Palomo
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2008
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-7-14

Other articles of this Issue 1/2008

Nutrition Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine